Login to Your Account

Financings Roundup

Enanta Raises $56M in IPO; Soars on First Day Trading

By Jennifer Boggs
Managing Editor

Thursday, March 21, 2013
Hepatitis C virus (HCV) player Enanta Pharmaceuticals Inc. priced a $56 million initial public offering (IPO) and received a warm welcome from Wall Street, as its newly listed shares shot up 22.7 percent on its first day of trading.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription